
Listen to the new episode of the Clinical Trial Files podcast, where Karin Avila, Taymeyah Al-Toubah and Thomas Wood of Fast Data Science chat about AI and NLP in pharma, the Clinical Trial Risk Tool, what impact AI can make in clinical trials. This episode commemorates Alan Turing’s 113rd birthday on 23 June 2025.
The group chatted about how a team of data scientists together with clinical professionals can be much greater than the sum of its parts, and what traditional machine learning, statistics, and generative AI can achieve in the clinical research field.
Thomas Wood also discussed the thinking behind Fast Data Science’s flagship product, the Clinical Trial Risk Tool, and why and how this tool came to exist and how it’s helping clinical researchers validate protocols. Karin and Taymeyah told us about the exciting developments in AI that they are seeing in clinical research.
The Clinical Trial Files podcast is organised by Karin Avila, Taymeyah Al-Toubah, and Roberto Torres. You can listen below on Spotify:
You can find the Clinical Trial Files podcast episode on
Looking for experts in Natural Language Processing? Post your job openings with us and find your ideal candidate today!
Post a Job
“Drug Name Recogniser: Chemical Structure, Formula & Molecular Weight” Google Chrome extension for pharmaceutical drug names Fast Data Science has developed a Google Chrome extension which finds pharmaceutical drug names in the web page you are viewing. It uses the same lookup as the Drug Named Entity Recognition Python library.
No part of this blog post constitutes legal advice. A common question that came up at the two expert witness conferences which I attended in 2026, was
There are a number of unresolved questions around when and how AI can be used in court documents. A variety of cases have been reported where litigants in person, advocates, or expert witnesses have been admonished or penalised by the courts for undeclared or inappropriate use of AI. In this post, I will focus on AI use in England and Wales, although I have covered some other jurisdictions in an earlier blog post on the topic.
What we can do for you